Current approach to seronegative myasthenia.
The group of patients with weakness or fatigue who have electrophysiological evidence of neuromuscular transmission defects, but no antibodies against either acetyl choline receptor or muscle specific kinase, need special evaluation and therapeutic consideration. Such seronegative patients may have low affinity antibodies but may also be late onset of a congenital myasthenic syndrome. This review discuss the practical approach toward the condition of seronegative myasthenia.
Argov
Zohar
Z
Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. zohara@ekmd.huji.ac.il
D003937:Diagnosis, Differential; D055724:Electrophysiological Phenomena; D005221:Fatigue / Q000209:etiology; D006801:Humans; D018908:Muscle Weakness / Q000209:etiology; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology